Total Number of Communication Reports: 0
Monthly communication reports in the last 6 months: 0
Subject matters | Details | Categories |
---|---|---|
Health
|
Federal public drug plans, specifically the Non-Insured Health Benefits Program (Health Canada), with respect to decisions and policies that impact reimbursement of therapeutic products for plan beneficiaries
|
Policies or Program
|
Health
|
Food and Drug Regulations specifically with respect to approval, regulation and life-cycle management of therapeutic products
|
Regulation
|
Health
|
Food and Drug Regulations with respect to Data Protection under. C.08.004
|
Policies or Program
|
Health
|
Food and Drugs Act, specifically with respect to the approval, regulation and life-cycle management of therapeutic products
|
Policies or Program
|
Health
|
Health Canada Health Products & Food Regulatory Modernization
|
Policies or Program
|
Health
|
Health care system policies or programs with respect to pharmaceuticals
|
Policies or Program
|
Intellectual Property
|
Patent Act as it relates to the regulation of intellectual property for therapeutic products
|
Policies or Program
|
Intellectual Property
|
Patent Act regulations as they relate to the regulation of intellectual property for therapeutic products and the Patented Medicines (Notice of Compliance) Regulations
|
Regulation
|
Intellectual Property
|
Patent Act with respect to Canada's Access to Medicines Regime (ss. 21.01-21.09)
|
Policies or Program
|
Health
|
Patented Medicine Prices Review Board with respect to regulations of reporting obligations of patentees
|
Policies or Program
|
Health
|
Patented Medicine Prices Review Board with respect to the regulation of pricing of patented drug products
|
Policies or Program
|
Health, International Trade
|
Proposed and potential policies with respect to current or potential regulation of cross-border trade in pharmaceuticals, including the Export Control List
|
Policies or Program
|
Economic Development, Industry, Intellectual Property, Research and Development, Science and Technology
|
Science and Technology Strategy led by Innovation, Science and Economic Development Canada, particularly with respect to the life sciences priority under the S&T Strategy
|
Policies or Program
|
Address:
2920 Matheson Blvd. East
Mississauga, ON L4W 5R6
Canada
Telephone number:
905-282-5550
Brandon Levac, Head, Market Access and Government Affairs
BAYER INC. is not a coalition.
The activities of BAYER INC. are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
BAYER INC. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Stephen Sampson | Public offices held
Firm: Global Public Affairs